Advertisement
Screener

PACIRA BIOSCIENCES, INC. (PCRX) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

PACIRA BIOSCIENCES, INC. Cash Flow Breakdown

Cash flow breakdown shows where PACIRA BIOSCIENCES, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $151.99M came in.
  • Fiscal year ended 2025-12-31: from investing, $99.48M came in.
  • Fiscal year ended 2025-12-31: from financing, $369.63M went out.
  • Fiscal year ended 2025-12-31: change in cash, $118.23M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDebt paid backNew debtCommercial paperStaff share taxNew shares soldNot split outChange in cash
2025-12-31$151.99M$99.48M-$148.33M$0.00$91.00M*-$5.62M$502.00K-$307.18M*-$118.23M
2024-12-31$189.39M-$83.28M-$25.00M$0.00$0.00*-$491.00K$0.00$42.85M*$123.48M
2023-12-31$154.65M$77.54M$0.00-$5.75M$0.00*-$106.00K$1.94M-$179.11M*$49.16M
2022-12-31$145.27M-$225.19M$0.00$0.00$0.00$0.00$24.39M-$425.92M*-$481.44M
2021-12-31$125.72M-$20.79M$0.00$363.75M$0.00$23.84M-$6.90M*$485.62M
2020-12-31$77.03M-$277.61M$0.00$45.22M$177.09M*$21.73M
2019-12-31$70.52M-$128.49M$0.00$8.47M-$4.80M*-$54.30M
2018-12-31$48.87M$20.58M$7.17M$1.78M*$78.40M
2017-12-31$17.79M-$223.76M$6.78M$217.38M*
2016-12-31$33.45M-$61.75M$5.77M$1.49M*
2015-12-31$28.02M-$19.26M$10.07M$626.00K*
2014-12-31$26.56M-$120.43M$0.00$0.00$7.24M$111.64M*
2013-12-31-$43.84M-$42.94M-$27.50M$3.86M$112.81M*
2012-12-31-$70.13M-$29.52M-$26.25M$27.50M$62.85M
2011-12-31-$31.00M-$36.12M$0.00$0.00$49.01M$38.15M*
2010-12-31-$24.88M-$6.77M-$2.00K-$11.25M$2.00K$61.95M*
2009-12-31-$20.84M-$5.51M$3.00K$21.04M*

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksDebt paid backNew debtCommercial paperStaff share taxNew shares soldNot split outChange in cash
2026-06-30$57.46M*$11.76M*$0.00*-$5.00M*-$3.49M*$457.00K*
2026-03-31$25.68M$19.44M-$50.05M-$5.00M-$4.36M$2.00K-$14.24M
2025-12-31$43.69M*$19.33M*-$48.25M*-$5.00M*-$143.00K*$490.00K*$1.25M*
2025-09-30$60.83M*$43.61M*-$50.04M*-$5.00M*-$8.00K*$12.00K*-$202.44M*
2025-06-30$12.01M*$62.16M*-$50.04M*$0.00*-$5.29M*$0.00*-$2.18M*
2025-03-31$35.46M-$25.63M$0.00$0.00-$181.00K$0.00-$2.81M*$6.84M
2024-12-31$33.13M*-$368.00K*$0.00*$0.00*$0.00*-$77.00K*$0.00*-$1.88M*
2024-09-30$53.92M*-$52.16M*$0.00*$0.00*$0.00*-$32.00K*$0.00*-$2.81M*
2024-06-30$53.24M*-$15.21M*$0.00*$0.00*-$378.00K*$0.00*$25.36M*
2024-03-31$49.10M-$15.53M$0.00$0.00-$4.00K$0.00-$2.81M*$30.75M
2023-12-31$47.58M*$8.37M*$0.00*$0.00*-$149.55M*-$106.00K*$0.00*$147.88M*
2023-09-30$44.44M*-$4.34M*$0.00*$0.00*$0.00*$0.00*$26.00K*-$27.81M*
2023-06-30$43.50M*$7.33M*$0.00*$0.00*$0.00*$1.58M*
2023-03-31$19.13M$66.18M-$5.75M$149.55M$0.00$333.00K-$298.04M*-$68.59M
2022-12-31$42.04M*$11.19M*$0.00*$0.00*$905.00K*-$59.42M*
2022-09-30$42.65M*-$47.52M*$0.00*$0.00*$1.60M*-$9.38M*
2022-06-30$29.81M*$19.16M*$0.00*$0.00*$10.86M*-$164.51M*
2022-03-31$30.78M-$208.02M$0.00$0.00$11.02M-$192.61M*-$358.83M
2021-12-31$23.21M*$66.92M*$4.79M*$356.61M*
2021-09-30$60.29M*-$35.08M*$3.05M*
2021-06-30$30.13M*$3.03M*$5.67M*
2021-03-31$12.08M-$55.66M$10.32M-$33.26M
2020-12-31$46.67M*-$82.32M*$9.24M*$1.13M*
2020-09-30$39.78M*-$202.85M*$29.63M*$180.13M*
2020-06-30-$15.62M*$36.12M*$0.00*$2.90M*$566.00K*
2020-03-31$6.21M-$28.57M$0.00$3.46M-$4.74M*-$23.64M
2019-12-31$25.90M*-$30.80M*$3.48M*-$5.50M*
2019-09-30$18.35M*$5.63M*$0.00*$1.42M*
2019-06-30$22.76M*-$181.80M*$0.00*$2.47M*$1.27M*
2019-03-31$3.50M$78.48M-$338.00K$1.10M$82.51M
2018-12-31$21.22M*-$123.16M*$2.70M*$832.00K*
2018-09-30$16.63M*$94.46M*$0.00*$2.98M*
2018-06-30$13.71M*$59.57M*$0.00*$1.07M*$952.00K*
2018-03-31-$2.69M-$10.29M$0.00$419.00K
2017-12-31$16.93M*$8.70M*$1.47M*$806.00K*
2017-09-30-$2.81M*-$27.48M*-$2.00K*$2.69M*
2017-06-30$3.66M*-$61.15M*-$479.00K*$1.76M*$1.06M*
2017-03-31$6.00K-$143.84M-$117.71M$852.00K$333.72M*
2016-12-31$17.35M*-$6.92M*
2016-09-30$11.68M*-$13.32M*$0.00*$769.00K*
2016-06-30$7.54M*-$19.64M*-$4.00K*$1.39M*$995.00K*
2016-03-31-$3.12M-$21.88M$0.00$3.04M
2015-12-31$16.99M*$7.30M*
2015-09-30$4.72M*-$8.74M*$1.82M*
2015-06-30$7.18M*-$18.01M*$2.93M*
2015-03-31-$870.00K$200.00K$4.05M
2014-12-31$26.56M-$120.43M$0.00*$7.24M$111.64M*
2014-09-30$8.36M*-$101.19M*$0.00*$2.38M*
2014-06-30$8.22M*-$30.57M*$0.00*$1.39M*$110.41M*
2014-03-31-$4.74M$9.02M$0.00$1.96M
2013-12-31-$6.90M*$15.22M*$0.00*$0.00*$813.00K*
2013-09-30-$9.84M*$3.62M*$0.00*$979.00K*
2013-06-30-$13.31M*-$5.52M*$0.00*$1.19M*
2013-03-31-$13.79M-$56.25M-$27.50M$877.00K$112.81M*
2012-12-31-$21.18M*$22.36M*$0.00*$0.00*$237.00K*
2012-09-30-$11.18M*-$1.81M*$0.00*$0.00*$0.00*
2012-06-30-$20.23M*-$47.54M*-$25.57M*$230.00K*$89.34M*
2012-03-31-$17.55M-$2.53M-$685.00K$153.00K
2011-12-31-$7.60M*-$11.77M*$124.00K*$49.01M*
2011-09-30-$8.49M*-$2.56M*$11.00K*
2011-06-30-$10.92M*-$20.96M*$0.00*
2011-03-31-$3.99M-$832.00K$1.00K$38.02M*
2010-12-31-$5.84M*-$2.95M*$0.00*$1.00K*$21.07M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
Savara Inc (SVRA)United States$1.044B-9.10
Corvus Pharmaceuticals, Inc. (CRVS)United States$0.994B-23.25
MANNKIND CORP (MNKD)United States$1.058B-30.41
Alto Neuroscience, Inc. (ANRO)United States$1.065B-11.02
Kura Oncology, Inc. (KURA)United States$0.967B-3.29
Arbutus Biopharma Corp (ABUS)$0.965B6.19
Jade Biosciences, Inc. (JBIO)United States$0.936B-9.21
Amphastar Pharmaceuticals, Inc. (AMPH)United States$1.116B10.93